PQS Phoqus

RNS Number:8368F
Phoqus Pharmaceuticals PLC
17 October 2007





                           Phoqus Pharmaceuticals plc



                           Directors' share dealings





West Malling, UK, 17 October 2007: Phoqus Pharmaceuticals plc (AIM: PQS)
("Phoqus" or the "Company"), the drug development company, announces dealings in
Company shares by Directors.



Anthony Playle, Non-Executive Director of the Company, exercised options over
40,843 ordinary shares ("Shares") in Phoqus (representing 0.09 per cent of the
issued share capital of the Company) at an exercise price of 0.01 pence per
ordinary share on 16 October 2007.  These share options were originally granted
by the Company on 3 November 2005.  Following the exercise of these share
options, Mr Playle has a total holding in the Company amounting to 40,947 Shares
(representing 0.09 per cent of the issued share capital of the Company).



As previously announced, share options granted by the Company on 3 November 2005
were to be satisfied by the transfer of Shares held by certain institutional
shareholders. In order to facilitate the transfer of Shares to option-holders,
some of the institutional shareholders transferred shares to Dr Peter Johnson,
Chief Financial Officer, to hold the Shares as their nominee pending exercise of
the share options by the option-holders, after which he would transfer the
relevant Shares to the exercising option-holders.



Accordingly, following the exercise of the above share options by Mr Playle,
together with share options exercised by other option-holders, Dr Johnson
transferred 101,779 Shares to the exercising shareholders in the usual way on 16
October 2007 in his capacity as nominee shareholder.



Following the above transfer of 101,779 Shares to exercising option-holders on
16 October, 177,740 Shares are now held by Dr Johnson in his capacity as
nominee, representing 0.39 per cent of the issued share capital of the Company.
Dr Johnson's beneficial ownership of Phoqus shares remains unchanged at 294,926
ordinary shares, or 0.64 per cent of the issued share capital of the Company.



Enquiries:



Phoqus Pharmaceuticals plc
Suzanne Smith, Company Secretary                             Tel: 01732 870227

Nomura Code Securities Limited
Phil Walker                                                  Tel: 020 7776 1200




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAEEXFENXFEE

Phoqus (LSE:PQS)
Historical Stock Chart
From May 2024 to Jun 2024

Phoqus (LSE:PQS)
Historical Stock Chart
From Jun 2023 to Jun 2024